Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal ...
How can dopamine orchestrate both learning and motivation? A recent study, published in Nature Communications, provides an ...